GI Dynamics, an obesity and diabetes device maker, continued its global expansion with the launch of its EndoBarrier gastrointestinal sleeve in the Netherlands, according to a MassDevice report.
GI & Endoscopy
German researchers found a mutation in the TFAP2E gene might play a part in chemo-resistant colorectal cancer, according to findings published in the New England Journal of Medicine.
Edward H. Livingston, MD, University of Texas Southwestern Medical Center, Dallas, and contributing editor for the Journal of the American Medical Association, wrote in a JAMA editorial that BMI is not always an adequate indicator for bariatric surgery.
A new study shows bariatric surgery is associated with a reduced number of cardiovascular deaths and events in obese patients, according to findings published in the Journal of the American Medical Association.
Roper St. Francis Cancer Care has become the first in South Carolina to use the da Vinci robot outfitted with Firefly fluorescence imaging to help make colon cancer surgery less invasive and more precise, according to a news release.
Scott Cunneen, MD, director of bariatric surgery at Cedars-Sinai Medical Center in Los Angeles, published his book, Weighty Issues: Getting the Skinny on Weight Loss Surgery, this week, according to a news release.
Glenn Littenberg, MD, chair, ASGE Practice Management Committee, future recipient of ASGE’s Distinguished Service Award at Digestive Disease Week 2012 and gastroenterologist at Huntington Hospital in Pasadena, Calif., shares his thoughts on the future of gastroenterology.
The end of December is the busiest time for many elective procedures, including weight loss surgeries such as gastric bypass, according to a Wall Street Journal report.
Peter Apicella, MD, chief of radiology at Salem Community Hospital says virtual CT colonoscopy involves a less intense preparation, does not require sedation, is less invasive and provides minimal disruption to a patient’s routine, in an article in MD News.
Researchers found obese patients were significantly less likely to have a tumor with deficient DNA mismatch repair status, a phenotype associated with improved outcomes in colorectal cancer, than normal-weight patients according to findings published in the Journal of Clinical Oncology.
